MBK Partners has acquired a 99.5 percent stake in Medit, a Seoul-based 3D dental scanner and solutions provider, from its largest shareholder, Unison Capital for 2.4 trillion won.
The acquisition took place a month after MBK was selected as the preferred bidder over the world's renowned private equity and investment firms, such as Carlyle, KKR, and Blackstone.
Medit founder Jang Min-ho and the firm's specially related parties also agreed to reinvest a considerable amount of revenue into the company. They will remain as joint investors with MBK. The deal is expected to close sometime around the first quarter of 2023.
The acquisition took place amid projections of the dental scanner market here and abroad growing 30 percent each year until 2027.
Medit is a global leader in the market for dental scanner solutions. The company secured a market share of 22 percent in 2020, and the portion rose to 24 percent this year.
The Korean firm started expanding its global footing in the industry from 2018 and has so far established branches in major countries such as the United States, Germany and China. The company runs 230 dealerships in around 100 countries across the globe.
Medit generated sales of 190.5 billion won last year, but this year's sales are estimated to have soared to around 270 billion won.
The dental scanner industry was an oligopoly market, with a group of top five companies accounting for more than 85 percent of the total market share. But the investment banking industry forecasts Medit and 3Shape to continue to expand their dominance in the industry and intensify a two-way rivalry.


CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
BOJ Hawk Signals Faster Interest Rate Hikes Amid Inflation Risks
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Gold Price Ends Lower for Fourth Week Despite Rebound as Fed Rate Hike Bets Strengthen
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
US Dollar Slips After PCE Inflation Data Eases Fed Rate Hike Expectations
White House Seeks $87.6 Billion Emergency Funding for Iran War, Farmers, and Ebola Response
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
South Korea’s KOSPI Jumps Over 5% as Samsung, SK Hynix Rally on Micron Earnings Boost
Oil Prices Drop as Strait of Hormuz Shipping Recovers 



